Skip to main content
Generix Group S.A. logo

Generix Group S.A. — Investor Relations & Filings

Ticker · GENX ISIN · FR0010501692 LEI · 9695003QNWHLC60H9E89 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 466 across all filing types
Latest filing 2013-07-22 Earnings Release
Country FR France
Listing PA GENX

About Generix Group S.A.

https://www.generixgroup.com/en

Generix Group is a global SaaS company that provides a portfolio of AI-powered, cloud-based solutions to streamline mission-critical digital processes in supply chain, finance, and commerce. The company's software suite is designed to help businesses build collaborative digital networks with their trading partners. Key offerings include Warehouse Management Systems (WMS), Transportation Management, B2B Integration, and automated invoice management. By digitizing the flow of goods and data, Generix Group enables organizations to optimize operations, enhance productivity, and manage end-to-end processes from procurement to payment and from order to delivery.

Recent filings

Filing Released Lang Actions
Generix Group : CA Q1 2013/2014
Earnings Release Classification · 98% confidence The document explicitly states it is the publication of the company's revenue ('chiffre d'affaires') for the first quarter (Q1) of the fiscal year 2013/2014, ending June 30, 2013. It presents key financial figures (Licenses, Maintenance, SaaS, Total Revenue) in a summarized table and discusses business dynamics. This content structure—a brief announcement focusing on period-specific financial highlights rather than a comprehensive, audited report (like 10-K) or a detailed management discussion (like MDA)—is characteristic of an Earnings Release (ER). Although it mentions future reports and risks (AMF reference), the primary purpose is the immediate release of quarterly financial performance metrics. Q1 2013
2013-07-22 French
Bilan semestriel du contrat de liquidité GENERIX
Capital/Financing Update Classification · 99% confidence The document is dated July 9, 2013, and is titled 'Bilan semestriel du contrat de liquidité GENERIX contracté avec NATIXIS' (Semi-annual balance sheet of the liquidity contract). It details the holdings (shares and cash) in a liquidity contract as of June 30, 2013, compared to the previous balance on December 31, 2012. This document specifically reports on the status of a liquidity agreement, which is a form of capital/financing arrangement, often related to share stabilization or market making. While it is a periodic report, it is highly specific to a financing mechanism rather than a general financial performance report (like IR or 10-K). Given the options, 'Capital/Financing Update' (CAP) is the most appropriate fit as it concerns the management of company capital/shares via a contract with a financial institution (NATIXIS). It is not a general earnings release (ER) or an interim report (IR).
2013-07-09 French
Generix Group : Déclaration de droits de vote et d'actions au 30 juin 2013
Regulatory Filings Classification · 95% confidence The document is dated July 9, 2013, and explicitly references Article L. 233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulation. It presents a table detailing the 'total number of shares' and 'theoretical voting rights' as of June 30, 2013. This structure is characteristic of a mandatory regulatory disclosure in France concerning the total voting rights and share capital, which is often published periodically. While it contains voting rights information, it is not the results of a vote (DVA) or a general management/board announcement (MANG). It is a specific regulatory disclosure related to capital structure and voting power. Given the options, this specific type of periodic capital/voting rights disclosure does not have a perfect dedicated code, but it is a regulatory filing. However, since it specifically details the total number of shares and voting rights, it is most closely related to capital structure updates or general regulatory reporting. Since it is a mandatory disclosure about the share count and voting rights, and not a general announcement of a report (RPA) or a director's trade (DIRS), the most appropriate general regulatory category is RNS, or potentially CAP if interpreted as a capital structure update. Given the precise nature of the disclosure (voting rights count), RNS (Regulatory Filings) serves as the best fit for this specific, non-standardized regulatory notice.
2013-07-09 French
Generix Group : Déclaration de droits de vote et d'actions au 31 mai 2013
Regulatory Filings Classification · 95% confidence The document is very short (537 characters) and explicitly states it provides 'Information relative au nombre total de droits de vote et d'actions' (Information relative to the total number of voting rights and shares) as required by French commercial code (Article L. 233-8 II) and AMF regulation (Article 223-16). This structure, detailing the total number of shares and theoretical voting rights as of a specific date (May 31, 2013), is characteristic of a mandatory regulatory disclosure concerning share capital structure, often related to ownership thresholds or voting power. While it is a specific regulatory disclosure, it does not fit perfectly into the defined categories like DIRS (Director's Dealing) or MRQ (Major Shareholding Notification). Given the focus on voting rights and share count, it is a specific regulatory filing. Since there is no specific code for 'Total Voting Rights Disclosure', the most appropriate general regulatory filing category is RNS (Regulatory Filings), as it is a mandatory disclosure to the market regulator (AMF). However, upon reviewing the definitions, none perfectly capture this specific type of capital/voting rights disclosure. Since it is a formal regulatory disclosure of share structure, and not a report announcement (RPA), RNS is the best fit as a general regulatory filing.
2013-06-10 French
Generix Group : strong growth in 2012/2013 results
Earnings Release Classification · 98% confidence The document explicitly states that Generix Group 'today issued the results for its fiscal year 2012/2013 ended March 31, 2013.' It contains detailed financial tables (IFRS consolidated accounts, EBITDA calculation, cash flows) and discusses performance metrics like EBITDA and Net Income for the full fiscal year. This content structure is characteristic of an Earnings Release (ER) which announces periodical financial results, often summarizing the key figures before a more comprehensive filing like the 10-K. Since it is an initial announcement of full-year results, 'ER' is the most appropriate classification, rather than '10-K' (the official annual report) or 'IR' (Interim/Quarterly Report). It is not a short announcement pointing to an attached report, so RPA/RNS is less likely. FY 2013
2013-06-03 English
Generix Group : forte croissance des résultats 2012/2013
Earnings Release Classification · 98% confidence The document is a press release dated June 3, 2013, announcing the financial results for the fiscal year 2012/2013, which ended March 31, 2013. It contains detailed consolidated financial tables (IFRS, non-audited) including Revenue, EBITDA, Operating Income, Net Income, and Cash Flow statements for the 12 months ended March 31, 2013, compared to 2011/2012. This structure—a formal announcement of period-end financial performance highlights—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) as it explicitly states the figures are 'non audité' (non-audited) and it is a press release format, not the comprehensive regulatory filing itself. It is also not an Interim Report (IR) as it covers the full fiscal year. FY 2013
2013-06-03 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.